We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sigma-Aldrich Signs Licensing Agreement with Epigentek Group
News

Sigma-Aldrich Signs Licensing Agreement with Epigentek Group

Sigma-Aldrich Signs Licensing Agreement with Epigentek Group
News

Sigma-Aldrich Signs Licensing Agreement with Epigentek Group

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sigma-Aldrich Signs Licensing Agreement with Epigentek Group"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sigma-Aldrich has signed a licensing agreement with Epigentek Group to further develop and commercialize technologies for Epigenetics research.

Under this agreement, Sigma-Aldrich gains rights to core Epigentek technologies, including DNA modification, methylation quantitation and protein/DNA interaction. This agreement is exclusive in the U.S. and co-exclusive globally.

"Sigma-Aldrich has identified Epigenetics as a growing area of interest and research for heritable diseases such as cancer, Alzheimer's and many others," said Keith Jolliff, Director of Genomics and Functional Genomics at Sigma-Aldrich. "We see the licensing with Epigentek as the right fit to our ongoing commitment to provide best-in-class solutions to the research community and an excellent entry point to supporting Epigenetics research."

Sigma-Aldrich plans to launch a family of products for Epigenetic research, beginning with the Imprint DNA Modification Kit in June 2007. The Company aims to provide customers a complete Epigenetic solution from DNA purification and bisulfite conversion to detection. Other products launching under the Imprint brand include kits for global methylation quantitation and chromatin immunoprecipitation based on Epigentek's technologies.

Epigentek offers procedures for Bisulfite DNA modification and chromatin immunoprecipitation. Their DNA modification technology provides DNA conversion for methylation analysis in less than two hours and requires only 50 picograms of starting DNA.

Advertisement